U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H19NO2S.C4H4O4
Molecular Weight 405.465
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of TENILOXAZINE MALEATE

SMILES

OC(=O)\C=C/C(O)=O.C(OC1=C(CC2=CC=CS2)C=CC=C1)C3CNCCO3

InChI

InChIKey=ONQAJVWRFPPADI-BTJKTKAUSA-N
InChI=1S/C16H19NO2S.C4H4O4/c1-2-6-16(19-12-14-11-17-7-8-18-14)13(4-1)10-15-5-3-9-20-15;5-3(6)1-2-4(7)8/h1-6,9,14,17H,7-8,10-12H2;1-2H,(H,5,6)(H,7,8)/b;2-1-

HIDE SMILES / InChI

Molecular Formula C16H19NO2S
Molecular Weight 289.393
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula C4H4O4
Molecular Weight 116.0722
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Teniloxazine (also known as sulfoxazine or sufoxazine or Y 8894) was developed as an antidepressant. Teniloxazine belongs to the selective norepinephrine reuptake inhibitors (NRIs) and was studied for the treatment of the major depressive disorder. Clinical trials have shown that 50 mg of the drug lacked the anticholinergic, sedative and cardiovascular effects. In the elderly, some effects were recognized, in part, due to pharmacokinetic alteration. In addition, teniloxazine was studied for patients with Alzheimer's disease, however, doesn’t exist any development report for this study.

Approval Year

PubMed

PubMed

TitleDatePubMed
[Pharmacological studies on sufoxazine (Y-8894). (I) Effects on experimental amnesia in mice].
1985 Feb
[Pharmacological studies on Y-8894. (III). Its effect on the abnormal electrocorticogram induced by destruction of the internal capsule].
1986 Oct
The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents.
2019 Jun

Sample Use Guides

Y-8894 (TENILOXAZINE) 50 mg
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 07:55:48 GMT 2023
Edited
by admin
on Sat Dec 16 07:55:48 GMT 2023
Record UNII
1BY0CJ6QWX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TENILOXAZINE MALEATE
JAN  
Common Name English
TENILOXAZINE MALEATE [JAN]
Common Name English
MORPHOLINE, 2-((2-(2-THIENYLMETHYL)PHENOXY)METHYL)-, (Z)-2-BUTENEDIOATE (1:1)
Systematic Name English
Code System Code Type Description
PUBCHEM
6438129
Created by admin on Sat Dec 16 07:55:49 GMT 2023 , Edited by admin on Sat Dec 16 07:55:49 GMT 2023
PRIMARY
CAS
62473-80-7
Created by admin on Sat Dec 16 07:55:49 GMT 2023 , Edited by admin on Sat Dec 16 07:55:49 GMT 2023
PRIMARY
FDA UNII
1BY0CJ6QWX
Created by admin on Sat Dec 16 07:55:49 GMT 2023 , Edited by admin on Sat Dec 16 07:55:49 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY